[HTML][HTML] Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly …

P Rossing, ML Caramori, JCN Chan, HJL Heerspink… - Kidney international, 2022 - Elsevier
The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline
for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of …

Evidence-based clinical practice guidelines for Liver Cirrhosis 2020

H Yoshiji, S Nagoshi, T Akahane, Y Asaoka… - Journal of …, 2021 - Springer
The first edition of the clinical practice guidelines for liver cirrhosis was published in 2010,
and the second edition was published in 2015 by the Japanese Society of Gastroenterology …

Red blood cell transfusion: 2023 AABB international guidelines

JL Carson, SJ Stanworth, G Guyatt, S Valentine… - Jama, 2023 - jamanetwork.com
Importance Red blood cell transfusion is a common medical intervention with benefits and
harms. Objective To provide recommendations for use of red blood cell transfusion in adults …

An update on management of adult patients with acute respiratory distress syndrome: an official American Thoracic Society Clinical Practice Guideline

N Qadir, S Sahetya, L Munshi, C Summers… - American journal of …, 2024 - atsjournals.org
Background: This document updates previously published Clinical Practice Guidelines for
the management of patients with acute respiratory distress syndrome (ARDS), incorporating …

Diabetes management in chronic kidney disease: synopsis of the KDIGO 2022 clinical practice guideline update

SD Navaneethan, S Zoungas, ML Caramori… - Annals of internal …, 2023 - acpjournals.org
Description: The KDIGO 2022 Clinical Practice Guideline for Diabetes Management in
Chronic Kidney Disease is an update of the 2020 guideline from Kidney Disease: Improving …

KDIGO 2021 clinical practice guideline for the management of glomerular diseases

BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - kidney-international.org
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke

E Berge, W Whiteley, H Audebert… - European stroke …, 2021 - journals.sagepub.com
Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …

Infertility prevalence and the methods of estimation from 1990 to 2021: a systematic review and meta-analysis

CM Cox, ME Thoma, N Tchangalova… - Human …, 2022 - academic.oup.com
STUDY QUESTION What is the contemporary prevalence of infertility in world populations
and how do they differ by methodological and study characteristics? SUMMARY ANSWER …

European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke

S Alamowitch, G Turc, L Palaiodimou… - European Stroke …, 2023 - journals.sagepub.com
Within the last year, four randomised-controlled clinical trials (RCTs) have been published
comparing intravenous thrombolysis (IVT) with tenecteplase and alteplase in acute …

European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis

LH Bonati, S Kakkos, J Berkefeld… - European stroke …, 2021 - journals.sagepub.com
Atherosclerotic stenosis of the internal carotid artery is an important cause of stroke. The aim
of this guideline is to analyse the evidence pertaining to medical, surgical and endovascular …